VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
BIIB
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
BIIBBiogen Inc.
$216.63$32.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksBIIBQuarterly Financials

Biogen Inc. (BIIB) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Biogen Inc. (BIIB) quarterly income statement — complete revenue, gross profit & net income history

BIIB Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue2.48B2.28B2.45B2.65B2.43B2.45B2.47B2.46B2.29B2.39B2.53B2.46B2.46B2.54B2.51B2.59B2.53B2.73B2.78B2.77B
Revenue Growth %1.93%-7.15%-0.45%7.33%6.13%2.87%-2.55%0.36%-7%-6.2%0.87%-5.14%-2.72%-6.94%-9.73%-6.7%-6.02%-4.16%-17.69%-24.63%
Cost of Goods Sold661M496.3M876.6M946.2M577.9M583.5M638.7M955.8M498.1M618.3M659.6M592.7M662.8M570.9M469.5M484M753.9M660.1M511.8M459.7M
COGS % of Revenue26.68%21.77%35.71%35.77%23.77%23.77%25.9%38.78%21.75%25.91%26.07%24.13%26.91%22.44%18.72%18.69%29.78%24.15%18.42%16.57%
Gross Profit1.82B1.78B1.58B1.7B1.85B1.87B1.83B1.51B1.79B1.77B1.87B1.86B1.8B1.97B2.04B2.11B1.78B2.07B2.27B2.32B
Gross Margin %73.32%78.23%64.29%64.23%76.23%76.23%74.1%61.22%78.25%74.09%73.93%75.87%73.09%77.56%81.28%81.31%70.22%75.85%81.58%83.43%
Gross Profit Growth %-1.96%-4.71%-13.62%12.6%3.39%5.84%-2.33%-19.01%-0.43%-10.39%-8.25%-11.49%1.25%-4.85%-10.06%-9.08%-19.77%-12.21%-22.55%-29.21%
Operating Expenses1.42B1.84B964.4M1.11B1.12B1.36B1.25B1.14B1.1B1.26B1.55B1.17B1.23B1.41B1.17B1.17B1.25B1.57B1.47B1.84B
OpEx % of Revenue57.28%80.73%39.29%42%46.09%55.49%50.69%46.35%48.11%52.62%61.25%47.78%49.77%55.61%46.6%45.14%49.51%57.31%52.81%66.47%
Selling, General & Admin607.3M683M594.8M581.3M574.6M678.7M576.9M550.3M578.3M608.1M752.7M536.5M605M638.2M563.3M572.6M634.9M799.2M654.1M637.3M
SG&A % of Revenue24.51%29.97%24.23%21.97%23.64%27.65%23.4%22.33%25.25%25.48%29.75%21.84%24.56%25.09%22.46%22.12%25.08%29.23%23.54%22.97%
Research & Development573M509.3M369.6M529.9M545.9M683.5M673M592.3M523.7M647.5M797.2M637.1M620.8M776.6M605.7M596.1M618.6M767.6M813.4M1.21B
R&D % of Revenue23.13%22.34%15.06%20.03%22.46%27.84%27.29%24.03%22.86%27.13%31.51%25.94%25.2%30.53%24.15%23.02%24.43%28.08%29.27%43.5%
Other Operating Expenses1000K1000K000000000000000000
Operating Income397.4M-57M613.8M588.1M732.6M509M577.2M366.5M690.4M512.4M320.8M689.7M574.4M558.3M870M936.4M524.4M506.9M799.6M470.8M
Operating Margin %16.04%-2.5%25%22.23%30.14%20.74%23.41%14.87%30.14%21.47%12.68%28.08%23.32%21.95%34.68%36.17%20.71%18.54%28.77%16.97%
Operating Income Growth %-45.75%-111.2%6.34%60.46%6.11%-0.66%79.93%-46.86%20.2%-8.22%-63.13%-26.35%9.53%10.14%8.8%98.9%-46.15%253.33%-26.4%-76.16%
EBITDA533.9M298.7M816M782.4M915.8M693M760M525.4M837.9M652.5M445.8M807.1M686.7M678.1M990.7M1.07B667.5M641.6M932.8M588M
EBITDA Margin %21.55%13.1%33.24%29.57%37.67%28.23%30.82%21.32%36.58%27.34%17.62%32.86%27.88%26.65%39.49%41.37%26.36%23.47%33.57%21.19%
EBITDA Growth %-41.7%-56.9%7.37%48.92%9.3%6.21%70.48%-34.9%22.02%-3.78%-55%-24.65%2.88%5.69%6.21%82.18%-37.99%390.45%-22.34%-71.83%
D&A (Non-Cash Add-back)136.5M355.7M202.2M194.3M183.2M184M182.8M158.9M147.5M140.1M125M117.4M112.3M119.8M120.7M134.8M143.1M134.7M133.2M117.2M
EBIT417.1M-57M624.7M915.6M681.9M507.7M531.6M809.5M632.4M461.1M270.5M633.3M517.3M645.1M824.7M907M641.7M578.4M821.8M504M
Net Interest Income-29.7M-30.3M-35.8M-40.3M-36.1M-41.5M-48.2M-41.2M-51.8M-47.7M32.1M26.8M18.4M-4.9M-36M-53.2M-63.2M-63.5M-63.7M-53.7M
Interest Income37.9M37.2M31.6M32.3M23.9M18.5M11.6M20.1M17.4M23.8M95.9M75.9M80.9M49.9M23.9M12.6M2.9M2.8M2.6M2.7M
Interest Expense67.6M67.5M67.4M72.6M60M60M59.8M61.3M69.2M71.5M63.8M49.1M62.5M54.8M59.9M65.8M66.1M66.3M66.3M56.4M
Other Income/Expense-19.7M-154M-56.5M155.9M-421.4M-217.5M-126.2M332.2M-225.6M-220.8M-462M18.4M-136.1M45.5M501.1M339M-180.3M-84.2M-507.4M145.6M
Pretax Income377.7M-211M557.3M744M311.2M291.5M451M698.7M464.8M291.6M-141.2M708.1M438.3M603.8M1.37B1.28B344.1M422.7M292.2M616.4M
Pretax Margin %15.24%-9.26%22.7%28.12%12.8%11.88%18.29%28.35%20.29%12.22%-5.58%28.83%17.8%23.73%54.66%49.26%13.59%15.46%10.51%22.21%
Income Tax58.2M-162.59M90.8M109.2M70.7M24.8M62.5M115.1M71.4M42.7M-72.9M114.8M50.7M54.3M236.2M216.7M125.6M443.2M-25.9M-409.1M
Effective Tax Rate %15.41%77.06%16.29%14.68%22.72%8.51%13.86%16.47%15.36%14.64%51.63%16.21%11.57%8.99%17.23%16.99%36.5%104.85%-8.86%-66.37%
Net Income319.5M-48.41M466.5M634.8M240.5M266.7M388.5M583.6M393.4M249.7M-68.1M591.6M387.9M550.4M1.13B1.06B303.8M368.2M329.2M448.5M
Net Margin %12.89%-2.12%19%24%9.89%10.86%15.76%23.68%17.18%10.46%-2.69%24.09%15.75%21.64%45.23%40.86%12%13.47%11.85%16.16%
Net Income Growth %32.85%-118.15%20.08%8.77%-38.87%6.81%670.48%-1.35%1.42%-54.63%-106%-44.08%27.68%49.48%244.68%135.9%-25.94%2.88%-53.07%-70.92%
Net Income (Continuing)319.5M-48.41M466.5M634.8M240.5M266.7M388.5M583.6M393.4M248.9M-68.3M593.3M387.6M549.5M1.13B1.06B218.5M-20.5M318.1M1.03B
Discontinued Operations00000000000000000000
Minority Interest0000000000-4.1M-6.4M-9.6M-9.5M-8.7M-9.1M-21.6M63.5M451.8M462.9M
EPS (Diluted)2.15-0.333.174.351.641.832.664.002.701.71-0.474.072.673.797.847.242.062.502.222.99
EPS Growth %31.1%-118.03%19.17%8.75%-39.26%7.02%665.96%-1.72%1.12%-54.88%-105.99%-43.78%29.61%51.6%253.15%142.14%-23.42%7.76%-50.22%-68.82%
EPS (Basic)2.17-0.333.184.351.651.832.674.012.711.72-0.474.092.693.827.867.252.062.512.223.00
Diluted Shares Outstanding148.4M146.7M147.1M145.9M145.9M146.1M145.9M145.9M145.9M145.7M144.8M145.5M145.2M145.2M144.8M146.2M147.6M147.5M148.6M150.1M
Basic Shares Outstanding147.2M146.7M146.6M145.9M145.9M145.7M145.7M145.6M145.2M144.9M144.8M144.7M144.4M144.1M144.4M145.9M147.1M146.9M148M149.7M
Dividend Payout Ratio--------------------